InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
62,776.61
(
-0.18%
)
Post# of 251706
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

willyw

Send PM Follow Ignore
Followers 14
Posts 733
Boards Moderated 0
Alias Born 12/09/2013

willyw

Re: DewDiligence post# 182969

Monday, 10/20/2014 12:23:41 PM

Monday, October 20, 2014 12:23:41 PM

Post# of 251706
Agree 100%.

My point is that Abbvie will soon know the value of what *could* become ENTA's greatest asset; ABT-493. Readouts are happening as we speak.

It occurs to me that the commercial value that you refer to, Abbvie also has a VERY good idea, since they probably at this point know exactly where they will price the 3-D program.

They will do it in a manner which should best commercialize the 3D program.

So yes, the analysts may be playing catch up.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up